Vexim, the Specialist in Minimally-Invasive Anatomical Restoration of Vertebral Compression Fractures, Announces Positive Clinical Trial Results and t

TOULOUSE, France– (BUSINESS WIRE) — As part of its pre-marketing studies, Vexim, a high-technology company specialized in medical instrumentation, and in the minimally-invasive anatomical treatment of vertebral compression fractures, announced positive clinical trial results and achievement of its recruitment objective of 120 patients by June 15th.

Over a year ago, Vexim initiated two clinical studies, including an international trial with 8 centers in Germany, France, Spain, Portugal and Turkey. This clinical work (featuring 120 patients and a 12 month follow-up period) has helped to optimise the SpineJack® implant with a view to market launch in 2009 within the next few weeks.

By successfully completing these studies, Vexim has proved the efficacy of its SpineJack® implant for the controlled, morphological restoration of vertebral compression fractures. Following implantation of the SpineJack®, all patients experienced rapid pain relief and correction of post-trauma deformation (visually assessed by conventional radiography, computed tomography scanning and a very accurate three-dimensional mapping tool developed in the LBM lab at the Paris ENSAM engineering school).

Josh Sandberg

Josh Sandberg is the President of Ortho Spine Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Themed By Curio Display Cabinets